EUVIMEDEUVIMED entdecken
Historischer Beitrag

Advancing cardiovascular research: Gemma Vilahur talks about her pioneering heart health discoveries

Judith Ozkan

European Heart Journal · 2024

DOI: 10.1093/eurheartj/ehae034 ↗

Kurz gefasst

Historischer Beitrag in der Zeitschrift European Heart Journal, 2024. Verfasst von Judith Ozkan. Hauptthemen laut MEDLINE: Cardiology, Cardiovascular Diseases, Biomedical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gemma Vilahur DVM, PhD, is a group leader at the Research Institute Hospital de la Santa Creu I Sant Pau (IR-HSCSP) in Barcelona, Spain. A veterinarian by training, she has a PhD in cardiovascular medicine and her research focuses on elucidating the basic mechanisms underlying vascular and heart disease pathology and discovering and evaluating potential new therapeutic targets and approaches (Figure 1). Gemma Vilahur DVM, PhD I was very curious from an early age and have always been fascinated by the idea of contributing to society by positively impacting human health. Since I wanted to focus on translational medicine, I studied veterinary medicine at the Autonomous University of Barcelona and was later awarded a fellowship from the Spanish Ministry of Science, Innovation, and Health to complete a PhD on thrombosis and nitric oxide donors at the Spanish National Research Council. After completing my PhD under Professor Lina Badimon’s mentorship, in 2004, I went abroad for a post-doctoral stage at the Cardiovascular Institute at the Mount Sinai School of Medicine, New York, USA, which was led by Valentin Fuster. Under Juan José Badimon’s supervision, I had access to state-of-the-art facilities and innovative equipment, and this enriched my career and facilitated international collaborations by opening opportunities for professional growth and impact. Two years later, I returned to Spain to the Cardiovascular Science Catalan Institute led by Professor Badimon, where I consolidated my line of research in cardioprotection and coronary ischaemic disease, ranging from atherosclerosis and its cardiovascular risk factors to thrombosis and its clinical consequences. In 2018, I was appointed Group Leader at the IR-HSCSP in Barcelona. Mount Sinai Hospital in New York challenged me to step out of my comfort zone and fostered my personal growth. It also exposed me to different research cultures and unique learning opportunities. I would also like to mention the European Society of Cardiology where I first became involved as one of the Founders of the Scientists of Tomorrow (Council of Basic Cardiovascular Science) and further developed to being a Board Member of the Council of Basic Cardiovascular Science and Chair of the Working Group on Thrombosis. These positions of trust allowed me to interact and learn from renowned experts in the field, contribute to basic/translational/clinical education, and hone leadership and management skills. On top of this, my election as President of the European Society for Clinical Investigation in 2023 has posed new challenges that I am excited to face. Finally, I would like to highlight my current place of work, the IR-HSCSP in Barcelona, which represents a benchmark of complex, specialized tertiary care at a national and international level. The IR-HSCSP has provided me with opportunities to collaborate with different healthcare professionals and introduced me to patient care while providing me with continuous support to conduct my research projects and foster my entrepreneurial spirit. Professor Lina Badimon has played a decisive role in my professional and personal development as a mentor and role model not only because of her intelligence, achievements, and determination but also because of her strong work ethic. Professor Badimon has guided and inspired me throughout my career with constructive feedback and positive reinforcement that helped me improve and develop as a consolidated researcher. In addition, I was fortunate to have had the generous advice and guidance of Professors Juan José Badimon and Valentin Fuster at Mount Sinai, as well as Professors Teresa Padró and Antonio Bayés de Luna at the IR-HSCSP, who have undoubtedly contributed to my progression as a person and scientist. We are currently working on two principal areas of research in the field of atherosclerotic ischaemic heart disease. We have made important contributions to understanding the molecular and cellular processes that occur in the setting of myocardial infarction (MI) and the cardiac healing process, as well as the discovery of therapeutic strategies to prevent and treat ischaemic heart disease. As such, we have identified novel drug-related therapeutic approaches capable of reducing myocardial damage in the setting of MI, leading to an improvement in cardiac function and the attenuation of adverse left ventricular remodelling. This research has involved experimental models of ischaemic heart disease and state-of-the-art imaging modalities (nuclear magnetic resonance imaging, echocardiography, angioscopy, and flow Doppler), and now we are conducting studies in the clinical setting aiming to implement our discoveries to improve patient healthcare. These discoveries have resulted in my authorship of four International patents and the foundation of three spin-off companies to develop intellectual property. Moreover, our work has been recognized several times, including the L'Oreal-UNESCO Foundation for Women in Science Award (2012) and the Outstanding Achievement Award from the European Society of Cardiology (2019). We also delve into atherogenic dyslipidaemia, particularly on high-density lipoprotein (HDL) particles and triglycerides. By applying ‘omic’ technologies, we have deciphered the harmful effect of cardiovascular risk factors on HDL particles and identified potential therapeutic targets. We are currently assessing the cardio/vasculo-protective potential of novel HDL-nano constructs aiming to restore HDL function or enhance specific features. In parallel, we are also elucidating the complex role of triglycerides in inter-organ crosstalk and HDL–triglyceride interplay to better identify how to tackle lipid-based residual risk. Selecting a research area that interests you. Passion for your work will keep you motivated during challenging times, and you will not realize how hard you are working. Developing strong research skills and building a solid educational background in your field of interest. I would encourage young researchers to perform innovative research and embrace a mindset of lifelong learning as the research landscape is ever evolving. This will help you to publish your research in reputable journals and establish you as an expert in your field. I would also advise researchers to adopt an entrepreneurial mindset and have the courage to innovate. Building a strong professional network. Attend scientific meetings, workshops, and courses to connect with your peers and other professionals. Networking often leads to collaborations, funding opportunities, new perspectives, and expertise. Striving for a healthy work–life balance. Try to manage your priorities and fulfil other areas of your life. Overall, I would remind the new generation that research is a challenging and demanding but exciting journey in which you must stay curious and persistent and enjoy the learning experience. The under-representation of women in leadership positions within academia and research institutions is a fact. Women pursuing a successful research career often face challenges that may impact their trajectory (career interruptions due to maternity leave or caregiving responsibilities, societal expectations, and traditional gender roles, among others). I encourage young women to stay motivated, keep working hard, and not give up as they must empower the next generation of women leaders. All authors declare no disclosure of interest for this contribution.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CardiologyCardiovascular DiseasesBiomedical ResearchHumansHistory, 21st CenturyHistory, 20th Century

Zitieren

APA

Ozkan, J. (2024). Advancing cardiovascular research: Gemma Vilahur talks about her pioneering heart health discoveries. European Heart Journal. https://doi.org/10.1093/eurheartj/ehae034

Vancouver

Ozkan J. Advancing cardiovascular research: Gemma Vilahur talks about her pioneering heart health discoveries. European Heart Journal. 2024. doi:10.1093/eurheartj/ehae034

BibTeX
@article{Ozkan2024,
  author = {Ozkan, Judith},
  title = {Advancing cardiovascular research: Gemma Vilahur talks about her pioneering heart health discoveries},
  journal = {European Heart Journal},
  year = {2024},
  doi = {10.1093/eurheartj/ehae034}
}
Kostenlos starten →